Licensing Resources for Veterans
An Online Resource for Skilled Immigrants
Office of Policy & Legislative Affairs
Construction Codes
Community and Health Systems
Corporations, Securities & Commercial Licensing Bureau.
Michigan Office of Administrative Hearings and Rules
Professional Licensing
Search is currently unavailable. Please try again later.
The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Media Contact: LARA Communications 517-335-LARA (5272)
Email: mediainfo@michigan.gov
January 13, 2020 – The Marijuana Regulatory Agency (MRA) issued a health and safety advisory bulletin on Friday, January 10, 2020 due to the recall of medical marijuana product which failed safety compliance testing.
All affected medical marijuana is required to have a label affixed to the container that indicates the METRC number assigned to the marijuana product. Patients and caregivers should look for the production batch number associated with the product name or the individual package number which can be found under the name of the provisioning center at which the product was sold.
This recall affects the following products sold at three provisioning centers in the state of Michigan between 10/14/2019 and 1/6/2020:
Production batch: 1A4050100002330000000009
Product name: Orange Burst – Buds
Failed testing: Chemical Residue (Paclobutrazol)
Pharmaco, Inc. (License # PC-000249)
3650 Patterson RD
Bay City MI 48706
Individual Package # 1A4050100002330000000415
Pharmaco, Inc. (License # PC-000261)
3557 Wilder RD
Bay City MI 48706
Individual Package # 1A4050100002330000000416
Pharmaco, Inc. (License # PC-000205)
20561 Dwyer ST
Detroit MI 48234
Individual Package # 1A405010000233000000041
Patients or caregivers who have these affected medical marijuana products in their possession should return them to the provisioning center where they were purchased for proper disposal. Provisioning centers who carried the products must notify patients or caregivers who purchased these medical marijuana products of the recall.
